Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 1.41% | 164.93 | 0.7% | $1445.32m | |
| PFE | Pfizer Inc. | 0.18% | 33.83 | 0.9% | $1226.47m | |
| BMY | Bristol-Myers Squibb Co. | -0.70% | 62.35 | 1.0% | $870.41m | |
| MRK | Merck & Co., Inc. | 0.52% | 74.95 | 0.7% | $828.25m | |
| LLY | Eli Lilly & Co. | -0.61% | 203.27 | 1.1% | $823.19m | |
| ABBV | AbbVie, Inc. | 0.34% | 108.96 | 1.9% | $818.20m | |
| AZN | AstraZeneca Plc | -0.64% | 49.78 | 1.2% | $526.41m | |
| GSK | GlaxoSmithKline Plc | -0.09% | 34.65 | 0.2% | $268.57m | |
| NVS | Novartis AG | -0.02% | 87.41 | 0.2% | $202.61m | |
| SNY | Sanofi | -0.26% | 46.49 | 0.2% | $169.71m | |
| VTRS | Viatris, Inc. | 0.72% | 15.41 | 0.0% | $139.80m | |
| VERU | Veru, Inc. | 0.13% | 15.17 | 0.0% | $125.99m | |
| VYNE | VYNE Therapeutics, Inc. | -1.79% | 8.24 | 0.0% | $121.21m | |
| CVAC | CureVac NV | 1.92% | 100.05 | 0.0% | $110.85m | |
| NVO | Novo Nordisk A/S | 0.83% | 72.83 | 0.1% | $92.59m |
Company Profile
Novo Nordisk A/S is a healthcare company, which engages in the research, development, manufacture, and marketing of pharmaceutical products. It operates through the following segments: Diabetes & Obesity Care, and Biopharmaceuticals. The Diabetes & Obesity Care segment covers products for insulin; GLP-1 and related delivery systems; oral antidiabetic products; and obesity. The Biopharmaceuticals segment offers products for haemophilia; growth hormone therapy; and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsværd, Denmark.